25 XP   0   0   10

Relay Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Relay Therapeutics Inc together

PenkeI guess you are interested in Relay Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Relay Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Relay Therapeutics Inc

I send you an email if I find something interesting about Relay Therapeutics Inc.

Quick analysis of Relay Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Relay Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$5.73
Expected worth in 1 year
$4.22
How sure are you?
29.4%

+ What do you gain per year?

Total Gains per Share
$-1.51
Return On Investment
-18.2%

For what price can you sell your share?

Current Price per Share
$8.30
Expected price per share
$5.95 - $10.62
How sure are you?
50%

1. Valuation of Relay Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$8.30

Intrinsic Value Per Share

$-31.03 - $-36.70

Total Value Per Share

$-25.30 - $-30.96

2. Growth of Relay Therapeutics Inc (5 min.)




Is Relay Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$752m$892.8m-$86.9m-10.8%

How much money is Relay Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$83.7m-$64.3m-$19.4m-23.2%
Net Profit Margin2,056,958.3%-18,841.8%--

How much money comes from the company's main activities?

3. Financial Health of Relay Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#73 / 1031

Most Revenue
#329 / 1031

Most Profit
#981 / 1031

What can you expect buying and holding a share of Relay Therapeutics Inc? (5 min.)

Welcome investor! Relay Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Relay Therapeutics Inc.

What can you expect buying and holding a share of Relay Therapeutics Inc?

First you should know what it really means to hold a share of Relay Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Relay Therapeutics Inc is $8.3. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Relay Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Relay Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $5.73. Based on the TTM, the Book Value Change Per Share is $-0.38 per quarter. Based on the YOY, the Book Value Change Per Share is $0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Relay Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.64-7.7%-0.65-7.9%-0.55-6.7%-0.56-6.8%-0.56-6.8%
Usd Book Value Change Per Share-0.20-2.4%-0.38-4.6%0.101.2%0.344.1%0.344.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.20-2.4%-0.38-4.6%0.101.2%0.344.1%0.344.1%
Usd Price Per Share11.01-12.11-21.00-20.59-20.59-
Price to Earnings Ratio-4.32--4.61--9.74--5.31--5.31-
Price-to-Total Gains Ratio-54.77--36.09--32.95--30.44--30.44-
Price to Book Ratio1.92-1.95-3.12-3.59-3.59-
Price-to-Total Gains Ratio-54.77--36.09--32.95--30.44--30.44-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share8.3
Number of shares120
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.380.34
Usd Total Gains Per Share-0.380.34
Gains per Quarter (120 shares)-45.3340.47
Gains per Year (120 shares)-181.32161.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-181-1910162152
20-363-3720324314
30-544-5530486476
40-725-7340647638
50-907-9150809800
60-1088-10960971962
70-1269-1277011331124
80-1451-1458012951286
90-1632-1639014571448
100-1813-1820016191610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.016.00.05.9%1.016.00.05.9%1.016.00.05.9%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%5.012.00.029.4%5.012.00.029.4%5.012.00.029.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%5.012.00.029.4%5.012.00.029.4%5.012.00.029.4%

Fundamentals of Relay Therapeutics Inc

About Relay Therapeutics Inc

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for patients with advanced or metastatic FGFR2-altered solid tumors; RLY-2608, a lead mutant-PI3Ka inhibitor program that targets phosphoinostide 3 kinase alpha; and Migoprotafib (GDC-1971), an oral, small molecule, potent and selective inhibitor of the protein tyrosine phosphatase SHP2 that binds and stabilizes Src homology region 2 domain-containing phosphatase-2 (SHP2) as a monotherapy in patients with advanced or metastatic solid tumors. In addition, it has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; and Genentech, Inc. for the development and commercialization of GDC-1971. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Fundamental data was last updated by Penke on 2024-03-22 02:13:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Relay Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Relay Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Relay Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 8,349,500.0% means that $83,495.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Relay Therapeutics Inc:

  • The MRQ is 8,349,500.0%. The company is making a huge profit. +2
  • The TTM is 2,056,958.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ8,349,500.0%TTM2,056,958.3%+6,292,541.7%
TTM2,056,958.3%YOY-18,841.8%+2,075,800.0%
TTM2,056,958.3%5Y476,713.6%+1,580,244.6%
5Y476,713.6%10Y476,713.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8,349,500.0%-159.2%+8,349,659.2%
TTM2,056,958.3%-202.3%+2,057,160.6%
YOY-18,841.8%-263.0%-18,578.8%
5Y476,713.6%-452.4%+477,166.0%
10Y476,713.6%-589.0%+477,302.6%
1.1.2. Return on Assets

Shows how efficient Relay Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Relay Therapeutics Inc to the Biotechnology industry mean.
  • -9.9% Return on Assets means that Relay Therapeutics Inc generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Relay Therapeutics Inc:

  • The MRQ is -9.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.9%TTM-8.9%-0.9%
TTM-8.9%YOY-6.3%-2.6%
TTM-8.9%5Y-7.7%-1.3%
5Y-7.7%10Y-7.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.9%-12.5%+2.6%
TTM-8.9%-12.2%+3.3%
YOY-6.3%-11.2%+4.9%
5Y-7.7%-13.3%+5.6%
10Y-7.7%-14.6%+6.9%
1.1.3. Return on Equity

Shows how efficient Relay Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Relay Therapeutics Inc to the Biotechnology industry mean.
  • -11.1% Return on Equity means Relay Therapeutics Inc generated $-0.11 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Relay Therapeutics Inc:

  • The MRQ is -11.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -10.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.1%TTM-10.4%-0.7%
TTM-10.4%YOY-7.3%-3.1%
TTM-10.4%5Y-7.9%-2.5%
5Y-7.9%10Y-7.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.1%-16.0%+4.9%
TTM-10.4%-15.8%+5.4%
YOY-7.3%-13.9%+6.6%
5Y-7.9%-18.2%+10.3%
10Y-7.9%-19.1%+11.2%

1.2. Operating Efficiency of Relay Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Relay Therapeutics Inc is operating .

  • Measures how much profit Relay Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Relay Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 9,633,000.0% means the company generated $96,330.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Relay Therapeutics Inc:

  • The MRQ is 9,633,000.0%. The company is operating very efficient. +2
  • The TTM is 2,373,667.5%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ9,633,000.0%TTM2,373,667.5%+7,259,332.5%
TTM2,373,667.5%YOY-22,512.7%+2,396,180.2%
TTM2,373,667.5%5Y550,369.7%+1,823,297.8%
5Y550,369.7%10Y550,369.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9,633,000.0%-299.5%+9,633,299.5%
TTM2,373,667.5%-208.5%+2,373,876.0%
YOY-22,512.7%-280.2%-22,232.5%
5Y550,369.7%-459.9%+550,829.6%
10Y550,369.7%-596.9%+550,966.6%
1.2.2. Operating Ratio

Measures how efficient Relay Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of -95,637.00 means that the operating costs are $-95,637.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Relay Therapeutics Inc:

  • The MRQ is -95,637.000.
  • The TTM is -23,563.272.
Trends
Current periodCompared to+/- 
MRQ-95,637.000TTM-23,563.272-72,073.728
TTM-23,563.272YOY238.683-23,801.955
TTM-23,563.2725Y-5,469.007-18,094.265
5Y-5,469.00710Y-5,469.0070.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-95,637.0002.817-95,639.817
TTM-23,563.2723.181-23,566.453
YOY238.6833.609+235.074
5Y-5,469.0075.554-5,474.561
10Y-5,469.0077.396-5,476.403

1.3. Liquidity of Relay Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Relay Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 25.44 means the company has $25.44 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Relay Therapeutics Inc:

  • The MRQ is 25.442. The company is very able to pay all its short-term debts. +2
  • The TTM is 16.947. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ25.442TTM16.947+8.495
TTM16.947YOY18.171-1.224
TTM16.9475Y27.221-10.274
5Y27.22110Y27.2210.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ25.4423.987+21.455
TTM16.9474.440+12.507
YOY18.1715.569+12.602
5Y27.2216.158+21.063
10Y27.2216.492+20.729
1.3.2. Quick Ratio

Measures if Relay Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Relay Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 44.81 means the company can pay off $44.81 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Relay Therapeutics Inc:

  • The MRQ is 44.813. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 30.125. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ44.813TTM30.125+14.688
TTM30.125YOY32.462-2.337
TTM30.1255Y43.793-13.668
5Y43.79310Y43.7930.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ44.8133.653+41.160
TTM30.1254.158+25.967
YOY32.4625.515+26.947
5Y43.7936.012+37.781
10Y43.7936.206+37.587

1.4. Solvency of Relay Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Relay Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Relay Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.11 means that Relay Therapeutics Inc assets are financed with 10.9% credit (debt) and the remaining percentage (100% - 10.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Relay Therapeutics Inc:

  • The MRQ is 0.109. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.139. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.109TTM0.139-0.030
TTM0.139YOY0.129+0.010
TTM0.1395Y0.283-0.144
5Y0.28310Y0.2830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1090.336-0.227
TTM0.1390.330-0.191
YOY0.1290.267-0.138
5Y0.2830.367-0.084
10Y0.2830.378-0.095
1.4.2. Debt to Equity Ratio

Measures if Relay Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Relay Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 12.2% means that company has $0.12 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Relay Therapeutics Inc:

  • The MRQ is 0.122. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.162. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.122TTM0.162-0.040
TTM0.162YOY0.149+0.014
TTM0.1625Y0.115+0.047
5Y0.11510Y0.1150.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1220.376-0.254
TTM0.1620.398-0.236
YOY0.1490.334-0.185
5Y0.1150.431-0.316
10Y0.1150.476-0.361

2. Market Valuation of Relay Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Relay Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Relay Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -4.32 means the investor is paying $-4.32 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Relay Therapeutics Inc:

  • The EOD is -3.260. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.324. Based on the earnings, the company is expensive. -2
  • The TTM is -4.608. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.260MRQ-4.324+1.064
MRQ-4.324TTM-4.608+0.284
TTM-4.608YOY-9.737+5.129
TTM-4.6085Y-5.311+0.702
5Y-5.31110Y-5.3110.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.260-2.697-0.563
MRQ-4.324-2.422-1.902
TTM-4.608-2.709-1.899
YOY-9.737-4.116-5.621
5Y-5.311-6.257+0.946
10Y-5.311-6.478+1.167
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Relay Therapeutics Inc:

  • The EOD is -3.048. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.043. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.343. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.048MRQ-4.043+0.995
MRQ-4.043TTM-5.343+1.300
TTM-5.343YOY-11.801+6.459
TTM-5.3435Y-13.257+7.915
5Y-13.25710Y-13.2570.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.048-3.344+0.296
MRQ-4.043-2.939-1.104
TTM-5.343-3.486-1.857
YOY-11.801-5.592-6.209
5Y-13.257-8.464-4.793
10Y-13.257-8.872-4.385
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Relay Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.92 means the investor is paying $1.92 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Relay Therapeutics Inc:

  • The EOD is 1.448. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.921. Based on the equity, the company is underpriced. +1
  • The TTM is 1.954. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.448MRQ1.921-0.473
MRQ1.921TTM1.954-0.034
TTM1.954YOY3.120-1.165
TTM1.9545Y3.585-1.631
5Y3.58510Y3.5850.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.4482.198-0.750
MRQ1.9212.042-0.121
TTM1.9542.121-0.167
YOY3.1202.907+0.213
5Y3.5853.682-0.097
10Y3.5854.114-0.529
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Relay Therapeutics Inc.

3.1. Institutions holding Relay Therapeutics Inc

Institutions are holding 99.123% of the shares of Relay Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31SB INVESTMENT ADVISERS (UK) LTD21.27242.73462790496300
2023-12-31Vanguard Group Inc8.1190.002610650387980250.9289
2023-12-31BlackRock Inc7.2980.00279573423124365614.9303
2023-12-31T. Rowe Price Associates, Inc.6.54160.01278581167-27779-0.3227
2023-12-31Casdin Capital, LLC5.6327.984573879434643696.7071
2023-12-31JPMorgan Chase & Co4.62390.0064606559592911118.0885
2023-12-31Bellevue Group AG4.52520.99975936082105108221.5165
2023-12-31State Street Corporation3.73810.00264903578-3011-0.0614
2023-12-31ArrowMark Colorado Holdings, LLC (ArrowMark Partners)2.98390.475739142461036672.7205
2023-12-31NORGES BANK2.33950.00593068973128065071.6118
2023-09-30Bvf Inc1.80350.53652365805-754716-24.1856
2023-12-31Geode Capital Management, LLC1.58680.002420815101105225.6074
2023-12-31Goldman Sachs Group Inc1.49930.001919667741075169120.588
2023-12-31Boxer Capital LLC1.38680.9983181913200
2023-09-30Citadel Advisors Llc1.28290.00316828491374834446.3529
2023-12-31Alphabet Inc1.19590.8009156875300
2023-12-31FMR Inc1.10910.00121454943-652790-30.9712
2023-12-31Dimensional Fund Advisors, Inc.1.03610.0044135915534148733.5558
2023-12-31Nextech Invest AG1.02642.7614134640915000012.5375
2023-12-31Finepoint Capital LP1.00464.5777131787044700051.328
Total 80.00521.9151104949557+7231276+6.9%

3.2. Funds holding Relay Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BB Biotech AG Ord3.71631.6762487500077500018.9024
2024-02-29Vanguard Total Stock Mkt Idx Inv2.78380.0024365171600
2023-12-31US Small-Cap Growth II Equity Comp2.36410.13753101142-9913-0.3186
2023-12-31T. Rowe Price New Horizons2.36410.1383101142-9913-0.3186
2024-02-29SPDR® S&P Biotech ETF2.34690.38963078675575401.9046
2024-02-29Vanguard Small Cap Index2.30150.02153019113286640.9585
2023-12-31T. Rowe Price Health Sciences1.96170.19262573330-53466-2.0354
2024-02-29iShares Russell 2000 ETF1.68810.03562214454-362-0.0163
2024-01-31JPMorgan Small Cap Growth A1.58450.53322078505-60765-2.8405
2024-01-31JPM Global Healthcare C (acc) USD1.50280.3994197139800
2024-02-29Vanguard Small Cap Growth Index Inv1.29150.04861694178281531.6898
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.02590.013213457017850.0584
2023-12-31Vanguard Explorer Inv0.85460.05771121009440704.0922
2023-12-31Fidelity Small Cap Index0.68750.0391901826106531.1954
2024-02-01iShares Russell 2000 Value ETF0.65110.065985405310800.1266
2024-01-31Fidelity Growth Compy Commingled Pl O0.5780.0098758266-51165-6.3211
2023-09-30UBS: US Equity Small Cap Growth0.570.292874774100
2024-02-29iShares Biotechnology ETF0.49710.0859652074-2935-0.4481
2023-12-31T. Rowe Price Integrated US Sm Gr Eq0.48050.089163030000
2023-12-31Meridian Growth Legacy0.45580.477159795500
Total 29.70584.705238967578+757426+1.9%

3.3. Insider Transactions

Insiders are holding 3.489% of the shares of Relay Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-29Thomas CatinazzoSELL20059.64
2024-01-29Peter RahmerSELL16519.64
2023-12-27Peter RahmerSELL24411.51
2023-12-27Thomas CatinazzoSELL29411.51
2023-10-30Peter RahmerSELL13546.03
2023-10-30Thomas CatinazzoSELL16976.03
2023-09-27Donald A BergstromSELL6488.38
2023-09-27Thomas CatinazzoSELL2948.38
2023-07-28Peter RahmerSELL135211.8
2023-07-28Thomas CatinazzoSELL169311.8
2023-06-27Donald A BergstromSELL64712.12
2023-06-27Thomas CatinazzoSELL29412.12
2023-04-28Peter RahmerSELL73911.16
2023-04-28Thomas CatinazzoSELL86311.16
2023-03-27Peter RahmerSELL29715.36
2023-03-27Thomas CatinazzoSELL34715.36

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Relay Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.201-0.378+88%0.100-301%0.337-160%0.337-160%
Book Value Per Share--5.7336.144-7%6.807-16%4.943+16%4.943+16%
Current Ratio--25.44216.947+50%18.171+40%27.221-7%27.221-7%
Debt To Asset Ratio--0.1090.139-22%0.129-16%0.283-62%0.283-62%
Debt To Equity Ratio--0.1220.162-25%0.149-18%0.115+6%0.115+6%
Dividend Per Share----0%-0%-0%-0%
Eps---0.636-0.652+2%-0.554-13%-0.561-12%-0.561-12%
Free Cash Flow Per Share---0.681-0.580-15%-0.455-33%-0.336-51%-0.336-51%
Free Cash Flow To Equity Per Share---0.514-0.514+0%0.098-625%0.175-393%0.175-393%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---36.695--------
Intrinsic Value_10Y_min---31.030--------
Intrinsic Value_1Y_max---1.884--------
Intrinsic Value_1Y_min---1.850--------
Intrinsic Value_3Y_max---7.028--------
Intrinsic Value_3Y_min---6.682--------
Intrinsic Value_5Y_max---13.818--------
Intrinsic Value_5Y_min---12.708--------
Market Cap1088785700.000-33%1444280790.0001588905637.500-9%2754431052.500-48%2700666953.529-47%2700666953.529-47%
Net Profit Margin--83495.00020569.583+306%-188.418+100%4767.136+1651%4767.136+1651%
Operating Margin--96330.00023736.675+306%-225.127+100%5503.697+1650%5503.697+1650%
Operating Ratio---95637.000-23563.272-75%238.683-40169%-5469.007-94%-5469.007-94%
Pb Ratio1.448-33%1.9211.954-2%3.120-38%3.585-46%3.585-46%
Pe Ratio-3.260+25%-4.324-4.608+7%-9.737+125%-5.311+23%-5.311+23%
Price Per Share8.300-33%11.01012.113-9%20.998-48%20.588-47%20.588-47%
Price To Free Cash Flow Ratio-3.048+25%-4.043-5.343+32%-11.801+192%-13.257+228%-13.257+228%
Price To Total Gains Ratio-41.289+25%-54.770-36.085-34%-32.946-40%-30.439-44%-30.439-44%
Quick Ratio--44.81330.125+49%32.462+38%43.793+2%43.793+2%
Return On Assets---0.099-0.089-10%-0.063-36%-0.077-23%-0.077-23%
Return On Equity---0.111-0.104-6%-0.073-35%-0.079-29%-0.079-29%
Total Gains Per Share---0.201-0.378+88%0.100-301%0.337-160%0.337-160%
Usd Book Value--752003000.000805976750.000-7%892898500.000-16%648360588.235+16%648360588.235+16%
Usd Book Value Change Per Share---0.201-0.378+88%0.100-301%0.337-160%0.337-160%
Usd Book Value Per Share--5.7336.144-7%6.807-16%4.943+16%4.943+16%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.636-0.652+2%-0.554-13%-0.561-12%-0.561-12%
Usd Free Cash Flow---89306000.000-76110500.000-15%-59638000.000-33%-44038235.294-51%-44038235.294-51%
Usd Free Cash Flow Per Share---0.681-0.580-15%-0.455-33%-0.336-51%-0.336-51%
Usd Free Cash Flow To Equity Per Share---0.514-0.514+0%0.098-625%0.175-393%0.175-393%
Usd Market Cap1088785700.000-33%1444280790.0001588905637.500-9%2754431052.500-48%2700666953.529-47%2700666953.529-47%
Usd Price Per Share8.300-33%11.01012.113-9%20.998-48%20.588-47%20.588-47%
Usd Profit---83495000.000-83758750.000+0%-64305750.000-23%-60732647.059-27%-60732647.059-27%
Usd Revenue---1000.0006386500.000-100%345250.000-100%6624117.647-100%6624117.647-100%
Usd Total Gains Per Share---0.201-0.378+88%0.100-301%0.337-160%0.337-160%
 EOD+3 -5MRQTTM+18 -15YOY+9 -245Y+10 -2310Y+10 -23

4.2. Fundamental Score

Let's check the fundamental score of Relay Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.260
Price to Book Ratio (EOD)Between0-11.448
Net Profit Margin (MRQ)Greater than083,495.000
Operating Margin (MRQ)Greater than096,330.000
Quick Ratio (MRQ)Greater than144.813
Current Ratio (MRQ)Greater than125.442
Debt to Asset Ratio (MRQ)Less than10.109
Debt to Equity Ratio (MRQ)Less than10.122
Return on Equity (MRQ)Greater than0.15-0.111
Return on Assets (MRQ)Greater than0.05-0.099
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Relay Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose8.110
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income Tax Expense  -24,18817,250-6,938-2,773-9,7118,348-1,36319,37518,012
Total Revenue 253-27226-10711925,08325,202-25,203-1



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets843,980
Total Liabilities91,977
Total Stockholder Equity752,003
 As reported
Total Liabilities 91,977
Total Stockholder Equity+ 752,003
Total Assets = 843,980

Assets

Total Assets843,980
Total Current Assets770,103
Long-term Assets73,877
Total Current Assets
Cash And Cash Equivalents 143,736
Short-term Investments 606,350
Other Current Assets 3,315
Total Current Assets  (as reported)770,103
Total Current Assets  (calculated)753,401
+/- 16,702
Long-term Assets
Property Plant Equipment 68,870
Intangible Assets 2,300
Long-term Assets Other 2,707
Long-term Assets  (as reported)73,877
Long-term Assets  (calculated)73,877
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities30,269
Long-term Liabilities61,708
Total Stockholder Equity752,003
Total Current Liabilities
Short-term Debt 4,964
Accounts payable 9,211
Other Current Liabilities 1,204
Total Current Liabilities  (as reported)30,269
Total Current Liabilities  (calculated)15,379
+/- 14,890
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt48,502
Long-term Liabilities Other 13,206
Long-term Liabilities  (as reported)61,708
Long-term Liabilities  (calculated)61,708
+/-0
Total Stockholder Equity
Common Stock127
Retained Earnings -1,400,582
Accumulated Other Comprehensive Income -196
Other Stockholders Equity 2,152,654
Total Stockholder Equity (as reported)752,003
Total Stockholder Equity (calculated)752,003
+/-0
Other
Capital Stock127
Cash and Short Term Investments 750,086
Common Stock Shares Outstanding 122,577
Current Deferred Revenue14,890
Liabilities and Stockholders Equity 843,980
Net Debt -90,270
Net Invested Capital 752,003
Net Working Capital 739,834
Property Plant and Equipment Gross 92,452
Short Long Term Debt Total 53,466



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
0
0
393,068
370,274
348,035
751,681
799,829
771,346
714,401
671,615
1,008,443
949,878
889,421
1,168,718
1,099,771
1,037,560
962,016
906,959
843,980
843,980906,959962,0161,037,5601,099,7711,168,718889,421949,8781,008,443671,615714,401771,346799,829751,681348,035370,274393,068000
   > Total Current Assets 
0
0
0
360,536
338,662
315,865
721,850
770,100
742,434
681,276
639,259
976,242
915,787
855,793
1,087,297
1,019,505
958,388
884,349
831,798
770,103
770,103831,798884,349958,3881,019,5051,087,297855,793915,787976,242639,259681,276742,434770,100721,850315,865338,662360,536000
       Cash And Cash Equivalents 
0
0
0
41,954
70,342
137,053
559,282
447,646
262,720
260,069
228,559
280,119
119,445
107,736
354,643
998,917
161,275
145,902
151,328
143,736
143,736151,328145,902161,275998,917354,643107,736119,445280,119228,559260,069262,720447,646559,282137,05370,34241,954000
       Short-term Investments 
0
0
0
313,862
263,861
175,153
154,184
230,415
463,355
411,151
387,949
677,954
778,733
730,254
699,149
847,123
776,529
725,671
659,287
606,350
606,350659,287725,671776,529847,123699,149730,254778,733677,954387,949411,151463,355230,415154,184175,153263,861313,862000
       Net Receivables 
0
0
0
0
0
0
0
82,654
8,606
4,472
5,055
4,940
4,946
5,052
5,117
5,219
5,231
78
211
0
0211785,2315,2195,1175,0524,9464,9405,0554,4728,60682,6540000000
       Other Current Assets 
0
0
0
4,720
4,459
3,659
8,384
9,385
7,753
5,584
17,696
13,229
12,663
12,751
11,580
3,259
4,085
3,392
3,678
3,315
3,3153,6783,3924,0853,25911,58012,75112,66313,22917,6965,5847,7539,3858,3843,6594,4594,720000
   > Long-term Assets 
0
0
0
32,532
31,612
32,170
29,831
29,729
28,912
33,125
32,356
32,201
34,091
33,628
81,421
80,266
79,172
77,667
75,161
73,877
73,87775,16177,66779,17280,26681,42133,62834,09132,20132,35633,12528,91229,72929,83132,17031,61232,532000
       Property Plant Equipment 
0
0
0
31,654
30,734
30,169
28,953
28,829
28,034
28,247
27,478
27,323
29,213
28,750
76,543
75,388
74,294
72,660
70,154
68,870
68,87070,15472,66074,29475,38876,54328,75029,21327,32327,47828,24728,03428,82928,95330,16930,73431,654000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
2,300
2,300
2,300
2,300
2,300
2,300
2,300
2,300
2,300
2,300
2,300
2,3002,3002,3002,3002,3002,3002,3002,3002,3002,3002,300000000000
       Other Assets 
0
0
0
0
878
2,001
878
23
878
2,578
2,578
2,578
2,578
2,578
2,578
2,578
0
2,707
0
0
002,70702,5782,5782,5782,5782,5782,5782,578878238782,0018780000
> Total Liabilities 
0
0
0
573,506
34,844
573,427
38,156
36,536
38,560
95,872
100,527
110,635
107,908
109,784
168,949
149,553
154,148
151,897
128,586
91,977
91,977128,586151,897154,148149,553168,949109,784107,908110,635100,52795,87238,56036,53638,156573,42734,844573,506000
   > Total Current Liabilities 
0
0
0
11,986
11,544
12,765
15,666
13,632
16,083
25,385
28,517
24,321
41,690
43,902
71,427
63,709
70,467
71,576
50,748
30,269
30,26950,74871,57670,46763,70971,42743,90241,69024,32128,51725,38516,08313,63215,66612,76511,54411,986000
       Short-term Debt 
0
0
0
1,249
1,308
1,370
1,433
1,521
1,623
1,695
1,768
1,844
1,922
2,002
5,681
4,276
4,441
4,610
4,785
4,964
4,9644,7854,6104,4414,2765,6812,0021,9221,8441,7681,6951,6231,5211,4331,3701,3081,249000
       Accounts payable 
0
0
0
6,991
3,958
2,830
4,553
6,351
5,593
7,871
6,316
8,276
8,053
4,296
9,485
10,578
11,834
14,778
13,353
9,211
9,21113,35314,77811,83410,5789,4854,2968,0538,2766,3167,8715,5936,3514,5532,8303,9586,991000
       Other Current Liabilities 
0
0
0
333
198
9,935
11,113
197
8,867
15,405
20,102
13,953
31,549
37,521
56,261
48,855
54,192
52,173
32,586
1,204
1,20432,58652,17354,19248,85556,26137,52131,54913,95320,10215,4058,86719711,1139,935198333000
   > Long-term Liabilities 
0
0
0
561,520
23,300
560,662
22,490
22,904
22,477
70,487
72,010
86,314
66,218
65,882
97,522
85,844
83,681
80,321
77,838
61,708
61,70877,83880,32183,68185,84497,52265,88266,21886,31472,01070,48722,47722,90422,490560,66223,300561,520000
       Other Liabilities 
0
0
0
0
58
9
6
3
0
48,465
50,465
65,258
45,663
45,863
42,922
32,378
0
29,223
0
0
0029,223032,37842,92245,86345,66365,25850,46548,4650369580000
       Deferred Long Term Liability 
0
0
0
0
0
1,123
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,12300000
> Total Stockholder Equity
0
0
0
-180,438
335,430
-225,392
713,525
763,293
732,786
618,529
571,088
897,808
841,970
779,637
999,769
950,218
883,412
810,119
778,373
752,003
752,003778,373810,119883,412950,218999,769779,637841,970897,808571,088618,529732,786763,293713,525-225,392335,430-180,438000
   Common Stock
0
0
0
4
66
5
90
90
90
92
92
109
109
109
121
121
121
122
123
127
12712312212112112110910910992929090905664000
   Retained Earnings Total Equity000-1,152,848-1,058,609-991,106-906,934-830,146-768,100-700,644-639,811-446,412-404,2280000000
   Accumulated Other Comprehensive Income 
0
0
0
325
1,394
631
176
64
12
-64
10
-1,088
-9,218
-11,906
-13,389
-10,420
-5,802
-6,081
-3,386
-196
-196-3,386-6,081-5,802-10,420-13,389-11,906-9,218-1,08810-6412641766311,394325000
   Capital Surplus 
0
0
0
0
10,619
0
0
1,167,367
1,179,096
1,258,312
1,271,630
1,666,887
1,681,225
1,698,368
2,004,143
2,019,126
2,041,941
0
0
0
0002,041,9412,019,1262,004,1431,698,3681,681,2251,666,8871,271,6301,258,3121,179,0961,167,3670010,6190000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
0
0
16,021
557,573
-522,717
401,082
1,167,367
407,750
1,258,312
1,271,630
1,666,887
1,681,225
1,698,368
2,004,143
2,019,126
2,041,941
2,067,431
2,098,723
2,152,654
2,152,6542,098,7232,067,4312,041,9412,019,1262,004,1431,698,3681,681,2251,666,8871,271,6301,258,312407,7501,167,367401,082-522,717557,57316,021000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue25,546
Cost of Revenue-5,269
Gross Profit20,27720,277
 
Operating Income (+$)
Gross Profit20,277
Operating Expense-404,968
Operating Income-373,000-384,691
 
Operating Expense (+$)
Research Development330,018
Selling General Administrative74,950
Selling And Marketing Expenses0
Operating Expense404,968404,968
 
Net Interest Income (+$)
Interest Income31,045
Interest Expense-0
Other Finance Cost-0
Net Interest Income31,045
 
Pretax Income (+$)
Operating Income-373,000
Net Interest Income31,045
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-341,973-379,404
EBIT - interestExpense = -385,844
-379,440
-341,973
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-385,844-341,973
Earnings Before Interest and Taxes (EBITDA)-380,575
 
After tax Income (+$)
Income Before Tax-341,973
Tax Provision-0
Net Income From Continuing Ops-341,973-341,973
Net Income-341,973
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses404,968
Total Other Income/Expenses Net6,404-31,045
 

Technical Analysis of Relay Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Relay Therapeutics Inc. The general trend of Relay Therapeutics Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Relay Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Relay Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.55 < 9.36 < 10.62.

The bearish price targets are: 7.4 > 5.95.

Tweet this
Relay Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Relay Therapeutics Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Relay Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Relay Therapeutics Inc.

Relay Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartRelay Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Relay Therapeutics Inc. The current adx is .

Relay Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Relay Therapeutics Inc.

Relay Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Relay Therapeutics Inc.

Relay Therapeutics Inc Daily Relative Strength Index (RSI) ChartRelay Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Relay Therapeutics Inc.

Relay Therapeutics Inc Daily Stochastic Oscillator ChartRelay Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Relay Therapeutics Inc.

Relay Therapeutics Inc Daily Commodity Channel Index (CCI) ChartRelay Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Relay Therapeutics Inc.

Relay Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartRelay Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Relay Therapeutics Inc.

Relay Therapeutics Inc Daily Williams %R ChartRelay Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Relay Therapeutics Inc.

Relay Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Relay Therapeutics Inc.

Relay Therapeutics Inc Daily Average True Range (ATR) ChartRelay Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Relay Therapeutics Inc.

Relay Therapeutics Inc Daily On-Balance Volume (OBV) ChartRelay Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Relay Therapeutics Inc.

Relay Therapeutics Inc Daily Money Flow Index (MFI) ChartRelay Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Relay Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Relay Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Relay Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose8.110
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Relay Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Relay Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Relay Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Relay Therapeutics Inc

I send you an email if I find something interesting about Relay Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Relay Therapeutics Inc.

Receive notifications about Relay Therapeutics Inc in your mailbox!